Mesenchymal stem cells: Cell-based reconstructive therapy in orthopedics

Tissue Engineering

Volumn 11, Issue 7-8, 2005, Pages 1198-1211

  Caplan, Arnold I ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; BIOMEDICAL ENGINEERING; BLOOD VESSELS; CELL CULTURE; ORTHOPEDICS; PATIENT TREATMENT;

CELL REPAIR; CELL-BASED RECONSTRUCTIVE THERAPY; CHICK LIMB; STEM CELLS;

CELLS;

ANIMAL CELL; BONE MARROW; BONE REMODELING; CARTILAGE; CELL CULTURE; CELL ISOLATION; CONFERENCE PAPER; CONNECTIVE TISSUE; EMBRYO; LIMB BUD; MESENCHYMAL STEM CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; BIOPROSTHESIS; CYTOLOGY; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; ORTHOPEDIC SURGERY; PHYSIOLOGY; PLASTIC SURGERY; PROSTHESIS; REVIEW;

RUMEX;

BIOPROSTHESIS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; ORTHOPEDIC PROCEDURES; PROSTHESIS DESIGN; RECONSTRUCTIVE SURGICAL PROCEDURES; TISSUE ENGINEERING;

EID: 24944503491     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2005.11.1198     Document Type: Conference Paper

References (78)

1. Caplan, A.I. Mesenchymal stem cells. J. Orthop. Res. 9, 641, 1991.
2. Caplan, A.I. The mesengenic process. Clin. Plast. Surg. 21, 429, 1994.
3. Haynesworth, S.E., Goldberg, V.M., and Caplan, A.I. Diminution of the number of mesenchymal stem cells as a cause for skeletal aging. In: Buckwalter, J.A., Goldberg, V.M., Woo, S.L.-Y., eds. Musculoskeletal Soft-Tissue Aging: Impact on Mobility. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1994, pp. 79-87.
4. Caplan A.I. Osteogenesis imperfecta: Rehabilitation medicine and fundamental research. Connect. Tissue Res. 31, S9, 1995.
5. Horwitz, E.M., Gordon, P.L., and Winston, K.K., et al. Isolated allogeneic bone marrow derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc. Natl. Acad. Sci. U.S.A. 99, 8932, 2002.
6. Horwitz, E.M., Prockop, D.J., and Fitzpatrick, L.A., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 5, 309, 1999.
7. Caplan, A.I. Effects of the nicotinamide-sensitive teratogen 3-acetylpyridine on chick limb cells in culture. Exp. Cell Res. 62, 341, 1970.
8. Caplan, A.I. The molecular control of muscle and cartilage development. In: Subtelney S, Abbott U, and Liss AR, eds. 39th Annual Symposium of the Society for Developmental Biology. New York: Alan R. Liss, 1981, pp. 37-68.
9. Caplan, A.I., and Koutroupas, S. The control of muscle and cartilage development in the chick limb: The role of differential vascularization. J., Embryol. Exp. Morphol. 29, 571, 1973.
10. Lucas, P.A., Syftestad, G.T., and Caplan, A.I. Partial isolation and characterization of a chemotactic factor from adult bone for mesenchymal cells. Bone 7, 365, 1986.
11. Lucas, P.A., Syftestad, G.T., and Caplan, A.I. A water-soluble fraction from adult bone stimulates the differentiation of cartilage in explants of embryonic muscle. Differentiation 37, 47, 1988.
12. Syftestad, G.T., and Caplan, A.I. A fraction from extracts from demineralized bone stimulates the conversion of mesenchymal cells into chondrocytes. Dev. Biol. 104, 348, 1984.
13. Syftestad, G.T., and Caplan, A.I. Effects of osteoinductive bone matrix extracts on the transition of mesenchymal cells into chondrocytes. Calcif. Tissue Int. 36, 625, 1984.
14. Syftestad, G.T., Lucas, P.A., and Caplan, A.I. The in vitro chondrogenic response of limb bud mesenchyme to a water-soluble fraction prepared from demineralized bone matrix. Differentiation 29, 230, 1985.
15. Wozney, J.M., Rosen, V., Celeste, A.J., et al. Novel regulators of bone formation: Molecular clones and activities. Science 242, 1528, 1988.
16. Caplan, A.I. Bioactive factors in bone: Marshall R. Urist, M.D. May 1988, Kerrville, Texas. Connect. Tissue Res. 23, 103, 1989.
17. Caplan, A.I. Cartilage begets bone vs. endochondral myelopoiesis. Clin. Orthop. Relat. Res. 261, 257, 1990.
18. Urist, M.R. Bone: Formation by autoinduction. Science 150, 893, 1965.
19. Urist, M.R., DeLange, R.J., and Finerman, G.A.M. Bone cell differentiation and growth factors. Science 220, 680, 1984.
20. Connolly, J.F., Guse, R., Tiedeman, J., and Dehne, R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin. Orthop. Relat. Res. 266, 259, 1989.
21. Friedenstein, A.J. Precursor cells of mechanocytes. Int. Rev. Cytol. 47, 327, 1976.
22. Freidensten, A.J., Chailakhyan, R.K., Latsinik, N.V., Panasyuk, A.F., and Keiliss-Borok, I.V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: Cloning in vitro and retransplantation in vivo. Transplantation 17, 331, 1974.
23. Owen, M. Lineage of osteogenic cells and their relationship to the stromal system. In: Peck, W.A., ed. Bone and Mineral. Amsterdam,: Elsevier, 1985, pp. 1-25.
24. Owen, J., and Friedenstein, A.J. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42, 1988.
25. Caplan, A.I., and Haynesworth, S.E. Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells. Patent no. 5,197,985, March 30, 1993.
26. Caplan, A.I., and Haynesworth, S.E. Method for treating connective tissue disorders. Patent no. 5,226,914, July 13, 1993.
27. Caplan, A.I., and Haynesworth, S.E. Human mesenchymal stem cells. Patent no. 5,486,359, January 23, 1996.
28. Caplan, A.I., and Haynesworth, S.E. Monoclonal antibodies for human osteogenic cell surface antigens. Patent no. 5,643,736, July 1, 1997.
29. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69, 1992.
30. Haynesworth, S.E., Goshima, J., Goldberg, V.M., and Caplan, A.I. Characterization of cells with osteogenic potential from human marrow. Bone 13, 81, 1992.
31. Lennon, D.P., Haynesworth, S.E., Bruder, S.P., Jaiswall, N., and Caplan, A.I. Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation. In Vitro Cell Dev. Biol. 32, 602, 1996.
32. Dennis, J.E., and Caplan, A.I. Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: Effects of pre-treatment with fibronectin or laminin. J. Oral Implant. 19, 106, 1993.
33. Dennis, I.E., Haynesworth, S.E., Young, R.G., and Caplan, A.I. Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: Effect of fibronectin and laminin on cell retention and rate of osteogenic expression. Cell Transplant. 1, 23, 1992.
34. Dennis, J.E., Konstantakos, E.K., Arm, D., and Caplan, A.I. In vivo osteogenesis assay: A rapid method for quantitative analysis. Biomaterials 19, 1323, 1998.
35. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL-1α. J. Cell. Physiol. 166, 585, 1996.
36. Ohgushi, H., and Caplan, A.I. Stem cell technology and bioceramics: From cell to gene engineering. J. BioMed. Mater. Res. 48, 913, 1999.
37. Awad, H., Huibregste, B., and Caplan, A.I., et al. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng. 5, 267, 1999.
38. Bruder, S.P., and Caplan, A.I. Discrete stages within the osteogenic lineage are revealed by alterations in the cell surface architecture of embryonic bone cells. In: Glimcher, M.J., and Lian, J.B., eds. The Chemistry and Biology of Mineralized Tissue. New York: Gordon and Breach, 1989, pp. 73-79.
39. Bruder, S.P., Fink, D.J., and Caplan, A.I. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration. J. Cell Biochem. 56, 283, 1994.
40. Bruder, S.P., Kraus, K.H., Goldberg, V.M., and Kadiyala, S. The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J. Bone Joint Surg. Am. 80A, 985, 1998.
41. Caplan, A.I., and Bruder, S.P. Cell and molecular engineering of bone regeneration. In: Lanza, R.P., Chick, W.L., and Langer, R., eds. Principles of Tissue Engineering. Austin, TX: R.G. Landes, 1996, pp. 599-618.
42. Caplan, A.I., and Bruder, S.P. Mesenchymal stem cells: Building blocks for molecular medicine in the 21st century. Trends Mol. Med. 6, 259, 2001.
43. Liebergall, M., Young, R.G., Ozawa, N., Caplan, A.I., et al. The effects of cellular manipulation and TGF-β in a composite graft. In: Brighton, C.T., Friedlaender, G.E., and Lane, J.M., eds. Bone Formation and Repair. Tampa, FL: American Academy of Orthopaedic Surgeons Symposium, 1994, pp. 367-378.
44. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J. Cell Biochem. 64, 295, 1997.
45. Johnstone, B., Hering, T.M., Goldberg, V.M., Yoo, J.U., and Caplan, A.I. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell Res. 238, 265, 1998.
46. Yoo, J.U., Solchaga, L.A., and Caplan, A.I., et al. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Bone Joint. Surg. 80, 1745, 1998.
47. Dennis, J.E., Awadallah, A., and Caplan, A.I. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner. Res. 14, 1, 1999.
48. b-tsA58 transgenic mouse. J. Cell. Physiol. 167, 523, 1996.
49. Wakitani, S., Saito, T., and Caplan, A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18, 1417, 1995.
50. Caplan, A.I., Elyaderani, M., Mochizuki, Y., Wakitani, S., and Goldberg, V.M. The principles of cartilage repair/regeneration. Clin. Orthop. Relat. Res. 342, 254, 1997.
51. Goldberg, V.M., and Caplan, A.I. Biological Resurfacing: An Alternative to Total Joint. Arthroplasty. Orthopedics 17, 819, 1994.
52. Goldberg, V.M., Solchaga, L.A., Yoo, J., Johnstone, B., and Caplan, A.I. Chondroprogenitor cell repair of full thickness defects of articular cartilage. J. Sports Traumatol. 20, 81, 1999.
53. Pei, M., Solchaga, L.A., and Caplan, A.I., et al. Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J. 16, 1691, 2002.
54. Solchaga, L.A., Dennis, J.E., Goldberg, V.M., and Caplan, A.I. Hyaluronic acid-based polymers as cell carriers for tissue engineered repair of bone and cartilage. J. Orthop. Res. 17, 205, 1999.
55. Solchaga, L.A., Dennis, J.E., and Caplan, A.I., et al. Hyaluronic acid-based polymers in the treatment of osteochondral defects. J. Orthop. Res. 18, 773, 2000.
56. Solchaga, L.A., Goldberg, V.M., and Caplan, A.I. Cartilage regeneration using principles of tissue engineering. Clin. Orthop. Suppl. 391, S161, 2001.
57. Wakitani, S., Goto, T., and Caplan, A.I., et al. Mesenchymal cell-based repair of large full-thickness defects of articular cartilage and underlying bone. J. Bone Joint. Surg. 76, 579, 1994.
58. Young, R.G., Fink, D.J., and Caplan, A.I., et al. The use of mesenchymal stem cells in achilles tendon repair. J. Orthop. Res. 16,406, 1998.
59. Caplan, A.I. Tissue engineering designs for the future: New logics, old molecules. Tissue Eng. 6, 1, 2000.
60. Kujawa, M.J., and Caplan, A.I. Hyaluronic acid bonded to cell culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cell cultures. Dev. Biol. 114, 504, 1986.
61. Kujawa, M.J., Carrino, D.A., and Caplan, A.I. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev. Biol. 114, 519, 1986.
62. Koc, O.N., Gerson, S.L., and Caplan, A.I., et al. Rapid hematopoietic recovery after coinfusion of autologous blood stem cells and culture expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high dose chemotherapy. J. Clin. Oncol. 18, 307, 2000.
63. Lazarus, H.M., Haynesworth, S.E., Gerson, S.L., Rosenthal, N., and Caplan, A.I. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells) [MPCs]: Implications for therapeutic use. Bone Marrow Transplant. 16, 557, 1995.
64. Allay, J.A., Dennis, J.E., and Caplan, A.I., et al. LacZ and IL-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. Hum. Gene Ther. 8, 1417, 1997.
65. Gao, J, Dennis, J.E., Muzic, R.F., Lundberg, M., and Caplan, A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169, 12, 2001.
66. Saito, T., Dennis, J.E., Lennon, D.P., Young, R.G., and Caplan, A.I. Myogenic expression of mesenchymal stem cells within myotubes of mdx mice in vitro and in vivo. Tissue Eng. 1, 327, 1996.
67. Askari, A.T., and Penn, M.S. Cell therapy for the treatment of ischemic heart disease: Approaching a new frontier. In: Topal, E.J., ed. Textbook of Interventional Cardiology. Philadelphia, PA: W.B. Saunders, 2003, pp. 1053-1061.
68. Askari, A.T., Unzek, S., and Penn, M.S., et al. Effect of stromal-cell-derived factor-1 on stem cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362, 697, 2003.
69. Shake, J.G., Gruber, P.J., Pittenger, M.F., et al. In vivo mesenchymal stem cell grafting in a swine myocardial infarct model: Molecular and physiologic consequences. Ann. Thoracic Surg. 73, 1919, 2002.
70. Toma, C., Pittenger, M.J., Cahill, K.S., Byrne, B.J., and Kessler, P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93, 2002.
71. Chen, J., Zhang, Z.G., and Chopp, M., et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ. Res. 92, 692, 2003.
72. Mahmood, A., Lu, D., Lu, M., and Chopp, M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53, 697, 2003.
73. Tykocinski, M.L., Kaplan, D.R., and Medof, M.E. Antigen-presenting cell engineering: The molecular toolbox. Am. J. Pathol. 148, 1, 1996.
74. Dennis, J.E., Cohen, N., Caplan, A.I., and Goldberg, V.M. Targeted delivery of progenitor cells for cartilage repair. J. Orthop. Res. 22, 735, 2004.
75. Pasqualini, R., and Ruoslahti, E. Organ targeting in vivo using phage display peptide libraries. Nature 380, 364, 1999.
76. Rajotte, D., Arap, W., and Ruoslahti, E., et al. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102, 430, 1998.
77. Arap, W., Kolonin, M.G., and Trepel, M., et al. Steps toward mapping the human vasculature by phage display. Nat. Med. 2, 121, 2002.
78. Caplan, A.I. Embryonic development and the principles of tissue engineering. Novartis Found. Symp. 249, 17, 2003.